Master of Biopharmaceutical Engineering (MBiopharmaE)

Program Code

MBE

Academic Year

2021

Special Notes

These Program Rules should be read in conjunction with the University's policies (http://www.adelaide.edu.au/policies).

Overview

The program will provide considerable insight to the engineering, technical, management and regulatory issues associated with the biopharmaceutical industry. The main aim of this program is to provide an internationally recognised high-quality flexible curriculum. The Master of Biopharmaceutical Engineering will incorporate state-of-the-art developments in science, engineering and technology. The program meets the needs for Science and Engineering graduates requiring qualifications that are relevant to the global biopharmaceutical industry.
 
The Master of Biopharmaceutical Engineering is an AQF Level 9 qualification with a standard full-time duration of 2 years.

Conditions

Interruption of program: Students must apply for permission from the Faculty before taking a Leave of Absence. Any extension of the leave without approval will result in the loss of place in the program but an application may be made to be re-admitted to the program subject to the admission procedures in place at the time.

Academic Program Rules for Master of Biopharmaceutical Engineering

There shall be a Master of Biopharmaceutical Engineering.

Qualification Requirements
Academic Program: 

To qualify for the degree of Master of Biopharmaceutical Engineering, the student must complete satisfactorily a program of study consisting of the following requirements with a combined total of not less than 48 units, comprising:

Core courses to the value of 18 units
Elective courses to the value of 12 units
Research project to the value of 18 units